Nancy Malla

Nancy Malla

Auto-generated profile, based on publicly available information

Nancy Malla

Postgraduate Institute of Medical Education and Research

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2004 in Annals of Clinical Microbiology and Antimicrobials
Verified
Journal Article
Open access
PDF file
DBDevendra Bansal
Devendra Bansal
RSRakesh Sehgal
Rakesh Sehgal
YCYogesh Chawla
Yogesh Chawla
RMRamesh Chander Mahajan
Ramesh Chander Mahajan
NMNancy Malla
Nancy Malla
Background: Amoebiasis is a major public health problem in tropical and subtropical countries. Although a number of antiamoebic agents are used for its treatment, yet the susceptibility data on clinical isolates of Entamoeba histolytica and Entamoeba dispar are not available. Therefore, the present study was aimed to assess the in vitro susceptibility of clinical isolates of E. histolytica and E. dispar to metronidazole, chloroquine, emetine and tinidazole. Methods: A total of 45 clinical isolates (15 E. histolytica and 30 E. dispar) were maintained in polyxenic cultures followed by monoxenic cultures. In vitro drug sensitivity (IC50) of clinical isolates and standard reference strain of E. histolytica (HM1: IMSS) was assessed by nitro blue tetrazolium (NBT) reduction assay after exposure to various concentrations of each drug. Results: The results showed that all clinical isolates had a higher IC50 compared to reference strain to all the four drugs. E. histolytica isolates appeared to be more susceptible [IC50 (μm) 13.2,26.3,31.2 and 12.4] compared to E. dispar isolates [IC50(μm) 15.6,28.9,32.8 and 13.2] and the reference strain of E. histolytica [IC50 (μm) 9.5, 15.5, 29.9 and 10.2] to the metronidazole, chloroquine, emetine and tinidazole respectively. Conclusions: The results indicate that till date, Entamoeba isolates in India do not seem to be resistant to the commonly used antiamoebic drugs.

1 January 2006 in Pathogens and Global Health
Verified
Journal Article
Closed access
JMJ. Mandal
J. Mandal
PSP. D. Singhi
P. D. Singhi
NKN. Khandelwal
N. Khandelwal
NMN. Malla
N. Malla
Although human neurocysticercosis (NCC) is being increasingly recognized in children, diagnosis of the disease can be difficult, and the 'gold standard' criteria that indicate an unambiguous case have still to be established. In the present study, the performances of an ELISA and dot-blot assay, for the detection of antibodies against antigens from larval Taenia solium, were investigated and compared, using sera, from children aged 5-12 years, that were diluted to at least 1:400. Eighty of the subjects (20 aged 5-<8 years and 60 older children) each had the signs and symptoms of NCC, including one brain lesion (N=69) or multiple brain lesions (N=11) that were visible by computed tomography. Another 100 sera, from children who had tubercular meningitis (N=20) or a parasitic disease other than taeniasis/cysticercosis (N=20) or, apart from a minor respiratory-tract infection, appeared healthy (N=60), were also investigated. Most (86%) of the cases of NCC had presented with focal seizures. Analysis of antibody response indicated that the optimum threshold titres for seropositivity were 1:800 for the ELISA and 1:6400 for the dot-blot assays. When used with these thresholds, the ELISA gave a sensitivity, specificity, positive and negative predictive values and diagnostic efficacy of 89%, 81%, 79%, 90%, 85%, respectively. The corresponding values for the dot-blot assay were similar, at 89%, 73%, 72.5%, 89%, 82%, respectively. Both assays were more sensitive, in the detection of the specific antibody response, when used among the paediatric cases of NCC who had multiple brain lesions (100%) than when used among the single-lesion cases (87%). As the ELISA gave higher specificity and diagnostic efficacy than the dot-blot assay, it should be considered the better method for the serological confirmation of NCC in children.

18 November 2008 in Parasite Immunology
Verified
Journal Article
Closed access
PDF file
Venkata AtluriVenkata Atluri
Venkata Atluri
PSP. Singhi
P. Singhi
NKN. Khandelwal
N. Khandelwal
NMN. Malla
N. Malla

24 April 2008 in Parasitology Research
Verified
Journal Article
Closed access
PDF file
SKSimernjeet Kaur
Simernjeet Kaur
SKSumeeta Khurana
Sumeeta Khurana
RBRashmi Bagga
Rashmi Bagga
AWAjay Wanchu
Ajay Wanchu
NMNancy Malla
Nancy Malla


6 March 2008 in Parasitology Research
Verified
Journal Article
Closed access
PDF file
JMJharna Mandal
Jharna Mandal
PSPratibha D. Singhi
Pratibha D. Singhi
NKNiranjan Khandelwal
Niranjan Khandelwal
NMNancy Malla
Nancy Malla